NMDA Receptor Modulator
-
NMDA Receptor Modulator (14)
- 1
-
Creatinine
0 ImagesCreatinine (NSC13123) is an orally active, blood-brain barrier-permeable modulator of GABAA and NMDA receptors, with activities of antioxidation and metabolic regulation. Creatinine is generated via non-enzymatic conversion of creatine and phosphocreatine in muscle. Creatinine serum levels correlate with muscle mass, glomerular filtration rate, and extrarenal clearance, serving as an evaluation biomarker for renal function, muscle mass, and clinical outcomes, and used for perioperative renal risk assessment. In addition, Creatinine can induce specific Cryptococcus species to produce creatinine deiminase and act as their nitrogen source, while it can be secreted via renal tubules. Creatinine is widely used in research related to various diseases such as neurodegenerative diseases, psychiatric disorders, acute kidney injury, chronic kidney disease, and renal failure.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
GNE 5729
0 ImagesGNE 5729 is an orally active, blood-brain barrier-penetrant positive allosteric modulator of NMDARs containing the GluN2A subunit. GNE 5729 enhances NMDAR responses through allosteric modulation, exhibits selectivity over other NMDAR subtypes and AMPARs, and can be used for research on depression.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
Rapastinel Trifluoroacetate
0 ImagesSynonyms: GLYX-13 TrifluoroacetateRapastinel (GLYX-13) Trifluoroacetate is a potent NMDAR modulator capable of crossing the blood-brain barrier, and it exhibits extremely high affinity for human NMDAR (EC50=0.0017-9.9 nM). Rapastinel Trifluoroacetate enhances ERK signaling and activates the mTOR pathway, thereby upregulating the expression of BDNF and VGF, and inducing significant neuroplastic changes such as enhanced LTP and increased mature dendritic spine density in the hippocampus. Rapastinel Trifluoroacetate moderately elevates the efflux of dopamine, norepinephrine and 5-HT in the prefrontal cortex, and uniquely avoids side effects of traditional antidepressants such as dissociation, addiction or sedation. Rapastinel Trifluoroacetate is applicable to the research of major depressive disorder and hepatocellular carcinoma.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
NYX-2925
0 ImagesNYX-2925 is an orally active, blood-brain barrier-permeable NMDAR modulator, with EC50 values of 55 pM, 28 fM, 11 pM and 55 pM against NR2A, NR2B, NR2C and NR2D, respectively. NYX-2925 enhances synaptic plasticity, long-term potentiation, metaplasticity, structural plasticity, learning ability, memory capacity and circadian rhythm amplitude. NYX-2925 regulates the signaling pathways of Src kinase, EIF2, mTOR, CDK5 and protein kinase A (PKA). NYX-2925 increases the levels of PSD-95, GluA1, activated Src and synaptic GluN2B. NYX-2925 is used in the research of neuropathic pain, fibromyalgia, painful diabetic peripheral neuropathy, post-traumatic stress disorder, cognitive impairment, depression, age-related cognitive decline and NMDAR-mediated central nervous system diseases.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
Rapastinel
0 ImagesSynonyms: GLYX-13Rapastinel (GLYX-13) is a potent NMDAR modulator capable of crossing the blood-brain barrier, and it exhibits extremely high affinity for human NMDAR (EC50=0.0017-9.9 nM). Rapastinel enhances ERK signaling and activates the mTOR pathway, thereby upregulating the expression of BDNF and VGF, and inducing significant neuroplastic changes such as enhanced LTP and increased mature dendritic spine density in the hippocampus. Rapastinel moderately elevates the efflux of dopamine, norepinephrine and 5-HT in the prefrontal cortex, and uniquely avoids side effects of traditional antidepressants such as dissociation, addiction or sedation. Rapastinel is applicable to the research of major depressive disorder and hepatocellular carcinoma.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
(R)-(+)-HA-966
0 ImagesSynonyms: (+)-HA-966(R)-(+)-HA-966 ((+)-HA-966) is a partial agonist/antagonist of glycine site of the N-methyl-D-aspartate (NMDA) receptor complex. (R)-(+)-HA-966 selectively blocks the activation of the mesolimbic dopamine system by amphetamine. (R)-(+)-HA-966 can cross the blood-brain barrier and has the potential for neuropathic and acute pain.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
UCM-A86
0 ImagesUCM-A86 is a selective positive allosteric modulator of GluN1/GluN3 NMDA receptors with EC50 values of 21 µM and 19 µM at GluN1/GluN3A and GluN1/GluN3B receptors, respectively. UCM-A86 selectively potentiates responses from GluN1/GluN3A/B over GluN1/GluN2A-D receptors. UCM-A86 can be used in the research of central nervous system diseases.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- UBP608
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
GluN2B-NMDAR Allosteric modulator 1
0 ImagesGluN2B-NMDAR Allosteric modulator 1 is a selective GluN2B-NMDAR positive allosteric modulator. GluN2B-NMDAR Allosteric modulator 1 can increase glutamate- and aspartate-evoked GluN2B-NMDAR-gated currents with EC50 values of 43.7 and 18 nM. GluN2B-NMDAR Allosteric modulator 1 can reverse anxiety-like behavior and social cognition deficits in mice. GluN2B-NMDAR Allosteric modulator 1 can be used for the research of neurological disease, such as anxiety.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
CNS0042
0 ImagesReferencia número: HY-183948No. CAS: 2419233-87-5CNS0042 is an allosteric modulator of NMDA receptor. CNS0042 can be used for the research of NMDA receptor-mediated neurological or psychiatric disease.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
NMDA receptor potentiator-1
0 ImagesReferencia número: HY-147352No. CAS: 486427-18-3NMDA receptor potentiator-1 (Compound 1368) is a subunit selective NMDA receptor potentiator with IC50s of 4 μM and 5 μM against NR2C and NR2D expression, respectively.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- NMDAR modulator 1
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
NMDAR modulator 3
0 ImagesReferencia número: HY-187147No. CAS: 342379-28-6NMDAR modulator 3 is a subunit-selective NMDA receptor potentiator targeting NMDAR receptors containing NR2C/NR2D subunits. NMDAR modulator 3 can be used for the research of schizophrenia, parkinson's disease, cognitive disorders, depression, neuropathic pain, stroke, traumatic brain injury, epilepsy, neurodegeneration.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
-
SGE-301
0 ImagesReferencia número: HY-15787No. CAS: 1427208-12-5SGE-301 is a positive, allosteric NMDAR modulator. SGE-301 recovers NMDAR density and long-term potentiation to normal values. SGE-301 can be used in the research of neurological disorders.
-
loading...Please select quantityObtener un presupuesto
August 31
-
Please select quantity
August 31
Obtener un presupuesto
loading... -
- 1